Selectivity of the collagen-binding integrin inhibitors, TC-I-15 and obtustatin.

Journal Information

Full Title: Toxicol Appl Pharmacol

Abbreviation: Toxicol Appl Pharmacol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of Competing Interest RWF is Chief Scientific Officer, CambCol Laboratories, Ely, Cambs, UK."

Evidence found in paper:

"This study was funded by grants from the 10.13039/501100000274British Heart Foundation: SP/15/7/31561 to RF; RG/15/4/31268 to RF, and FS/15/20/31335 to RF and EH."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025